Financing equitable access to antiretroviral treatment in South Africa

被引:13
|
作者
Cleary, Susan [1 ]
McIntyre, Di [1 ]
机构
[1] Univ Cape Town, Hlth Econ Unit, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa
来源
基金
新加坡国家研究基金会;
关键词
HEALTH; POLITICS; THERAPY; CARE; MANAGEMENT; COSTS;
D O I
10.1186/1472-6963-10-S1-S2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: While South Africa spends approximately 7.4% of GDP on healthcare, only 43% of these funds are spent in the public system, which is tasked with the provision of care to the majority of the population including a large proportion of those in need of antiretroviral treatment (ART). South Africa is currently debating the introduction of a National Health Insurance (NHI) system. Because such a universal health system could mean increased public healthcare funding and improved access to human resources, it could improve the sustainability of ART provision. This paper considers the minimum resources that would be required to achieve the proposed universal health system and contrasts these with the costs of scaled up access to ART between 2010 and 2020. Methods: The costs of ART and universal coverage (UC) are assessed through multiplying unit costs, utilization and estimates of the population in need during each year of the planning cycle. Costs are from the provider's perspective reflected in real 2007 prices. Results: The annual costs of providing ART increase from US$ 1 billion in 2010 to US$ 3.6 billion in 2020. If increases in funding to public healthcare only keep pace with projected real GDP growth, then close to 30% of these resources would be required for ART by 2020. However, an increase in the public healthcare resource envelope from 3.2% to 5%-6% of GDP would be sufficient to finance both ART and other services under a universal system (if based on a largely public sector model) and the annual costs of ART would not exceed 15% of the universal health system budget. Conclusions: Responding to the HIV-epidemic is one of the many challenges currently facing South Africa. Whether this response becomes a "resource for democracy" or whether it undermines social cohesiveness within poor communities and between rich and poor communities will be partially determined by the steps that are taken during the next ten years. While the introduction of a universal system will be complex, it could generate a health system responsive to the needs of all South Africans.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Financing equitable access to antiretroviral treatment in South Africa
    Susan Cleary
    Di McIntyre
    BMC Health Services Research, 10
  • [2] GENDER AND ACCESS TO ANTIRETROVIRAL TREATMENT IN SOUTH AFRICA
    Nattrass, Nicoli
    FEMINIST ECONOMICS, 2008, 14 (04) : 19 - 36
  • [3] ACCESS TO ANTIRETROVIRAL TREATMENT IN SOUTH AFRICA, 2004-2011
    Johnson, Leigh F.
    SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2012, (43) : 22 - 27
  • [4] Learning and equitable access in the Western Cape, South Africa
    Gilmour, David
    Soudien, Crain
    COMPARATIVE EDUCATION, 2009, 45 (02) : 281 - 295
  • [5] The role of risk adjustment in the equitable financing of National Health Insurance in South Africa
    McLeod, Heather
    DEVELOPMENT SOUTHERN AFRICA, 2012, 29 (05) : 636 - 656
  • [6] Implementing 'universal' access to antiretroviral treatment in South Africa: a scoping review on research priorities
    Myburgh, Hanlie
    Reynolds, Lindsey
    Hoddinott, Graeme
    van Aswegen, Dianne
    Grobbelaar, Nelis
    Gunst, Colette
    Jennings, Karen
    Kruger, James
    Louis, Francoise
    Mubekapi-Musadaidzwa, Constance
    Viljoen, Lario
    Wademan, Dillon
    Bock, Peter
    HEALTH POLICY AND PLANNING, 2021, 36 (06) : 923 - 938
  • [7] How children access antiretroviral treatment at Kgapane District Hospital, Limpopo, South Africa
    Railton, J.
    Mash, R.
    SOUTH AFRICAN FAMILY PRACTICE, 2012, 54 (03) : 229 - 236
  • [8] Equitable access to cell and gene therapies in South Africa: opportunities and hurdles
    Candice Laverne Hendricks
    Marco Alessandrini
    Michael Sean Pepper
    Gene Therapy, 2023, 30 : 180 - 186
  • [9] Equitable access to cell and gene therapies in South Africa: opportunities and hurdles
    Hendricks, Candice Laverne
    Alessandrini, Marco
    Pepper, Michael Sean
    GENE THERAPY, 2023, 30 (1-2) : 180 - 186